AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INTELLIGENT ULTRASOUND GROUP PLC

Report Publication Announcement Aug 3, 2020

7714_rns_2020-08-03_9fd34019-5ce6-4e95-8376-a41657646969.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8245U

Intelligent Ultrasound Group PLC

03 August 2020

Intelligent Ultrasound Group plc

("the Company")

Notice of Results

Analyst briefing

Intelligent Ultrasound Group plc (LSE: MED), the ultrasound artificial intelligence (AI) software and simulation company, announces it will issue its interim results for the six months ended 30 June 2020 on Thursday, 6 August 2020.

The Company will host a briefing for analysts via ZOOM at 9.30am on Thursday, 6 August. If you would like to register to dial in to the analyst briefing or require further information, please contact Walbrook PR on 020 7933 8780 or email [email protected]

For further information, please contact:

Intelligent Ultrasound Group plc www. intelligentultrasound.com
Stuart Gall, CEO 

Helen Jones, Group Finance Director
Tel: +44 (0)29 2075 6534
Cenkos Securities - Nominated Advisor and Broker Tel:  +44 (0)20 7397 8900
Giles Balleny / Cameron MacRitchie (Corporate Finance)
Michael Johnson / Julian Morse (Sales)
Walbrook PR Tel: +44 (0)20 7933 8780 or [email protected]
Anna Dunphy / Paul McManus Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: MED) develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity virtual reality simulators for the ultrasound training market.

Based in Cardiff and Oxford in the UK, Atlanta in the US and with representation in Beijing in Asia, the Group operates two divisions:

Clinical AI Division

Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible. Products in development include ScanNav which uses machine-learning based algorithms to automatically identify and grade ultrasound images to provide scan assessment and audit of protocol-based ultrasound scanning; and  AnatomyGuide, which aims to simplify ultrasound-guided needling by providing the user with real-time AI-based needle guidance software for a range of medical procedures.

Simulation Division

Focusses on hi-fidelity ultrasound education and training through simulation.  Its three main products are the ScanTrainer OBGYN training simulator, the HeartWorks echocardiography training simulator and the BodyWorks Eve Point of Care and Emergency Medicine training simulator. To date over 800 simulators have been sold to almost 500 medical institutions around the world.

www.intelligentultrasound.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

NORGZGFNKMFGGZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.